A fixed rule set over this filing's XBRL figures and the number of high-severity risks found in it — no model judgement.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
Ingersoll Rand delivered 8.5% YoY revenue growth to $2.05B and returned to net profitability with $256.8M in net income for Q2 FY2026, driven by organic demand, acquisition contributions, and the non-recurrence of prior-year impairment charges.
Revenue
$2.05B
+8.52% YoY
EPS (Diluted)
$0.66
+327.59% YoY
Gross Margin
42.1%
-1.6 pts YoY
Operating Income
$380.3M
+397.77% YoY
Filed · Source: SEC EDGAR 10-Q filing
Ingersoll Rand (IR) reported Q2 FY2026 revenue of $2.05B, up 8.5% year over year. The company posted net income of $256.8M, with diluted EPS of $0.66. Gross margin was 42.1%. Operating income was $380.3M, up 397.8% year over year. IR's fiscal Q2 FY2026 corresponds to calendar Q2 2026.
Ingersoll Rand reported Q2 FY2026 revenue of $2.05B (+8.5% YoY) and net income of $256.8M, benefiting from organic segment growth, acquisitions, and lower impairment costs.
Last 4 quarters: 2 beats, 2 misses
Adjusted (non-GAAP) EPS of $0.86 versus the $0.93 analyst consensus — a -7.9% miss for Jun 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $0.66.
Q2 FY2026 revenue increased 8.5% YoY to $2,048.8M from $1,887.9M, driven by $77.5M in organic growth, $53.4M from business acquisitions, and a $30.0M favorable impact from foreign currency translation.
Source: 10-Q Item 2 MD&A, p.40
Industrial Technologies and Services revenue rose 8.7% YoY to $1,622.1M with Adjusted EBITDA of $434.5M (margin 26.8%), while Precision and Science Technologies revenue grew 7.7% YoY to $426.7M with Adjusted EBITDA increasing 15.2% to $134.5M (margin expanding 200 bps to 31.5%).
Source: 10-Q Item 2 MD&A, p.46-47
Other operating expense (income), net improved by $41.0M YoY to $(21.1)M in Q2 FY2026, benefiting from a $25.0M recovery from representations and warranties settlement related to the ILC Dover transaction and reduced transaction-related expenses.
Source: 10-Q Item 2 MD&A, p.41, 44
Net income surged to $256.8M ($0.66 diluted EPS) compared to a net loss of $115.3M in Q2 2025, primarily due to the absence of $265.8M in goodwill and intangible asset impairments and $120.9M in equity investment losses recorded in the prior-year period.
Source: 10-Q Item 2 MD&A, p.42, 44
With approximately 56% of six-month revenues denominated in non-U.S. dollar currencies, fluctuations in foreign exchange rates pose an ongoing risk to operating results and monetary translation.
Source: 10-Q Item 2 MD&A, p.38
Potential shifts in U.S. trade policy, retaliatory international tariffs, and changing regulatory environments could introduce supply chain costs and impact international market competitiveness.
Source: 10-Q Item 2 MD&A, p.38
Short-term borrowings and current maturities of long-term debt increased to $699.8M at June 30, 2026 from $1.4M at year-end 2025, increasing liquidity management and short-term debt service requirements.
Source: 10-Q Balance Sheet (XBRL)
This analysis does not extract a guidance section. Companies issue revenue and EPS outlook in the 8-K press release and on the earnings call rather than in the 10-Q itself — though the filing's management discussion can contain forward-looking statements, which appear in the highlights above where they were material.
See the IR earnings preview — expected date, analyst estimates and what to watch →
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.05B | $1.89B | +8.52% |
Cost of Revenue | $1.19B | $1.06B | +11.59% |
Gross Profit | $862.6M | $824.9M | +4.57% |
Operating Income | $380.3M | $76.4M | +397.77% |
Net Income | $256.8M | -$115.3M | +322.72% |
EPS (Basic) | $0.66 | -$0.29 | +327.59% |
EPS (Diluted) | $0.66 | -$0.29 | +327.59% |
SG&A Expense | $400.8M | $371.2M | +7.97% |
Ingersoll Rand reported revenue of $2.05B (+8.5% YoY) and net income of $256.8M, turning around from a net loss of $115.3M in Q2 2025. Growth was driven by $77.5M in organic sales gains and $53.4M from acquisitions, alongside the absence of prior-year asset impairments.
Industrial Technologies & Services segment revenue grew 8.7% YoY to $1.62B with Adjusted EBITDA of $434.5M. Precision & Science Technologies revenue increased 7.7% YoY to $426.7M, while its Adjusted EBITDA surged 15.2% to $134.5M, expanding segment margin to 31.5%.
Net income rebounded to $256.8M primarily because Q2 2025 included $265.8M of goodwill and intangible impairments and $120.9M in equity investment losses that did not recur in Q2 FY2026. Profits were further aided by higher gross profit and a $25.0M representations and warranties settlement recovery.
Year-to-date operating cash flow reached $495.6M and free cash flow reached $432.3M (with Q2 single-quarter FCF at $268.9M). As of June 30, 2026, the company maintained $1.17B in cash and cash equivalents and $2.60B in available credit facility capacity.
Expected release date, analyst estimates & what to watch
IR (Ingersoll Rand) delivered Q1 FY2026 revenue of $1.85B (+7.6% YoY) and net income of $192.1M (+3.0% YoY), but margin compression and a 22.1% decline in operating cash flow signal rising cost pressures.
IR (Ingersoll Rand) reported FY2025 revenue growth of 5.7% to $7.65B, but profitability declined sharply with net income falling 30.7% to $581.4M, driven by higher SG&A costs and increased share buybacks that reduced EPS to $1.45 diluted.
Other companies in Industrial Machinery & Supplies & Components